Tijdschrift voor psychiatrie · 2021
[Ethical issues for the further development of psychiatric deep brain stimulation].
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Leentjens A F G, Schruers K, Ackermans P C M, Horstkötter D
Аннотация
BACKGROUND: Except in the case of obsessive-compulsive disorder, deep brain stimulation (DBS) for psychiatric indications is an experimental treatment, reserved for the most severe and treatment resistant cases.
AIM: To discuss ethical aspects for the further development of DBS in psychiatry.
METHOD: Ethical reflection.
RESULTS: The low number of patients and the experimental character of the treatment hamper the collection of scientific evidence and the safeguarding of patients being indicated for DBS. Apart from that, special care should be taken in assessing competency and the ability to provide informed consent.
CONCLUSION: Interest in the subjective experiences of patients being treated with DBS, proactive ethical reflection and an increase in the scale of research efforts are essential for the acceptance and further development of DBS for psychiatric indications.
AIM: To discuss ethical aspects for the further development of DBS in psychiatry.
METHOD: Ethical reflection.
RESULTS: The low number of patients and the experimental character of the treatment hamper the collection of scientific evidence and the safeguarding of patients being indicated for DBS. Apart from that, special care should be taken in assessing competency and the ability to provide informed consent.
CONCLUSION: Interest in the subjective experiences of patients being treated with DBS, proactive ethical reflection and an increase in the scale of research efforts are essential for the acceptance and further development of DBS for psychiatric indications.